BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2019
View Archived Issues
"Neoleukins" better than the real thing
Read More
"Exercise hormone" has role in synaptic plasticity, memory
Read More
KPNA1 influences sphingosine-sensitive anxiety pathways by regulating MeCP2 nuclear import
Read More
Orion Biotechnology's OB-002O reduces colorectal tumor growth in vivo
Read More
Novel insights into targets and mechanisms behind the neuroprotective effect of N-Acetylcysteine
Read More
VISTA found a potential therapeutic target in pancreatic cancer
Read More
Biomunex and Sanofi enter licensing agreement for bi- and multi-specific antibody therapeutics
Read More
Anti-CTLA-4 dual variable domain preserves antitumor effects while eliminating toxicity
Read More
EMA grants marketing authorization for macimorelin
Read More
Erleada approved in Europe for patients with nmCRPC at high risk of developing metastatic disease
Read More
Phase IIa study of UB-311 meets primary endpoint in patients with Alzheimer's disease
Read More
Pulmotect initiates phase II study of PUL-042
Read More
Top-line data presented from phase II study of NYX-2925 in painful diabetic peripheral neuropathy
Read More
How chondrocytes make the best of low-oxygen state
Read More
Chinfloxacin shows promising PK and safety profile in first-in-human study
Read More
Dual PI3K/HDAC inhibitors discovered at the U.S. Department of Health & Human Services
Read More
Macrophage integrin CD11b as novel therapeutic target for cancer immunotherapy
Read More
Ralexar Therapeutics patents oxysterols receptor LXR-beta agonists
Read More
FDA issues complete response letter for Opsumit sNDA for CTEPH
Read More
FDA clears IND for phase Ib study of Aivita's AV-MEL-1 in metastatic melanoma
Read More
Pharmaxis eyes phase II studies with LOXL2 inhibitors following completion of toxicity studies
Read More
ADC Therapeutics begins phase I trial of ADCT-601 in advanced or metastatic solid tumors
Read More
FDA accepts IND for phase Ib/IIa study of Hyleukin-7 with atezolizumab in high-risk skin cancers
Read More
Celleron completes phase Ib evaluation of CXD-101 with nivolumab
Read More
